DRKS00008579
Recruiting
Not Applicable
Follow-up investigation of former patients of a rehabilitation center (Leppermühle) with the diagnosis of adolescent schizophrenia - Leppermühle catamnesis
niversitätsklinikum Freiburg, Klinik für Psychiatrie, Psychotherapie und Psychosomatik im Kindes- und Jugendalter0 sites105 target enrollmentJuly 13, 2015
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- F20
- Sponsor
- niversitätsklinikum Freiburg, Klinik für Psychiatrie, Psychotherapie und Psychosomatik im Kindes- und Jugendalter
- Enrollment
- 105
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •children and Youngsters suffering from a schizophrenic psychosis, treated in the period from the 01\.01\.2002 to the 31\.12\.2004 in the child and youth home Leppermühle.
Exclusion Criteria
- •F20\.6\. Schizophrenia simplex, because the reliability and validity of this diagnosis is discussed very controverse.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
It is the study for analysis of patients of carcinoma esophagus and gastroesophageal junction who have received chemotherapy before.Health Condition 1: null- Patients of ca esophagus and gastroesophageal junction who have received docetaxel, platinum and 5-Fluorouracil as induction therapyCTRI/2014/08/004839ot applicable31
Recruiting
Phase 1
ong-Term Follow-Up of TX200-TR101 (STEADFAST Long Term)Kidney Transplant RejectionMedDRA version: 21.1Level: LLTClassification code: 10050436Term: Prophylaxis against renal transplant rejection Class: 10042613Therapeutic area: Phenomena and Processes [G] - Immune system processes [G12]CTIS2024-512580-31-00Sangamo Therapeutics France30
Not yet recruiting
Not Applicable
Outcomes following a Multimodal Pain Protocol in Total Knee ArthroplastyTotal knee arthroplasty post operative pain and mobilitySurgery - Other surgeryMusculoskeletal - OsteoarthritisACTRN12612000343808Dr Gerald Yeo100
Not yet recruiting
Not Applicable
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (TX200-TR101) in a prior clinical study.Allograft rejectionRenal transplant rejection1002766510029149NL-OMON56013Sangamo Therapeutics France SAS8
Active, not recruiting
Phase 1
ong-Term Follow-Up of Patients who have received an Autologous Antigen-Specific Chimeric Antigen Receptor T Regulatory Cell Therapy (CAR- Treg therapy, TX200-TR101) in a prior clinical study.Prevention of immune mediated allograft rejection in patients with end-stage renal disease (ESRD) who are tissue typed as HLA-A*02 negative and have received a kidney transplant from an HLA-A*02 positive living donor.MedDRA version: 21.1Level: LLTClassification code 10050436Term: Prophylaxis against renal transplant rejectionSystem Organ Class: 10042613 - Surgical and medical proceduresTherapeutic area: Body processes [G] - Immune system processes [G12]EUCTR2022-002440-40-DESangamo Therapeutics France SAS15